US Autism Research Initiative Controversy
Analysis based on 6 articles · First reported Apr 10, 2025 · Last updated Apr 11, 2025
The announcement by Robert F. Kennedy Jr. and Donald Trump to fund research into debunked theories about autism and vaccines could negatively impact public trust in health institutions and potentially affect pharmaceutical companies involved in vaccine production. The hiring of David Geier, a controversial figure, further exacerbates concerns among scientific and medical communities.
Robert F. Kennedy Jr., the Health and Human Services Secretary, announced a 'massive testing and research effort' to determine the cause of autism, to be completed by September. This initiative, supported by President Donald Trump, focuses on a discredited theory linking childhood vaccines to autism, despite scientific consensus to the contrary. Leading autism advocacy groups like Autism Speaks and the Autism Society of America disagree with this approach, with the latter expressing 'deep concern' about evaluating debunked theories. Robert F. Kennedy Jr. has hired David Geier, a controversial figure who has repeatedly claimed a vaccine-autism link and was found by United States — Maryland to be practicing medicine without a license, to lead the research. The United States — National Institutes of Health already spends over $300 million annually on autism research, identifying other risk factors.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard